Answers are grounded in this paper and cite their sources.
Previous studies showed conditional knockout of Liver Kinase B1 (LKB1) from astrocytes exacerbated disease severity and glial cell activation in a mouse model of multiple sclerosis (MS). A major function of LKB1 is to maintain energy supplies under conditions of metabolic stress, suggesting that loss of LKB1 could alter astrocytic metabolic processes. Following siRNA mediated knockdown (KD) of LKB1 from primary mouse astrocytes, untargeted metabolomic screening identified significant increases in Pantothenic Acid (PA) and related metabolites; and pathway analysis showed that the PA:Coenzyme A (PA:CoA) pathway was significantly modified. This pathway was also identified by bulk RNA sequencing. In LKB1 KD cells, relative mRNA levels of enzymes in the PA:CoA pathway were reduced, and PA Kinase 2 (Pank2, which converts PA to phosphoPA) expression was reduced. Deficiencies in Pank2 are known to cause iron accumulation, which we confirmed occurs in LKB1 KD astrocytes. The KD cells also showed increased sensitivity to induction of ferroptosis. Measurement of serum PA levels in a small cohort of relapsing remitting MS patients revealed a positive correlation with age at diagnosis in those patients harboring a variant in the gene encoding LKB1. Together, these results suggest that metabolic disturbances, in this case due to LKB1 depletion, can lead to dysregulation of the PA:CoA pathway in astrocytes.
No takes yet. Share an insight, caveat, or question.
Alemani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: